• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE Back to Search Results
Model Number 720081-01
Device Problems Inadequacy of Device Shape and/or Size (1583); Insufficient Information (3190); Migration (4003)
Patient Problems Discomfort (2330); Unspecified Tissue Injury (4559); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/12/2023
Event Type  Injury  
Event Description
It was reported that this tactra penile prosthesis was removed due to unspecified reasons.A new tactra penile prosthesis was implanted.No patient complications were reported.
 
Event Description
It was reported that this tactra penile prosthesis was removed as the corpus cavernosum had atrophied to the extent that a larger implant had to be inserted.The patient was not able to use the implant properly because it moved slightly and caused uncomfortable marks.A new tactra penile prosthesis was implanted.No patient complications were reported.
 
Manufacturer Narrative
Corrected data: g1 manufacturing site upon receipt of this tactra penile prosthesis at our quality assurance laboratory, the returned components underwent a thorough analysis.The tactra cylinders were visually inspected.The tactra cylinders were trimmed down to approximately 19.5 cm.Based on the information available and analysis results, the reported device issues were unable to be confirmed and the cause was not established.The analysis was also unable to confirm the reported clinical observations of atrophy and discomfort.The reported patient symptoms are a known risk associated with implant of these devices as indicated in the instructions for use.Based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
 
Event Description
It was reported that the corpus cavernosum of the patient with this tactra malleable penile prosthesis had atrophied to the extent that a larger implant had to be inserted.The patient was not able to use the implant properly because it moved slightly and caused uncomforatable marks.The device was explanted and replaced with another tactra.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTRA MALLEABLE PENILE PROTHESIS
Type of Device
PROSTHESIS PENILE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel MA
EI  
Manufacturer Contact
farshad fahimi
4100 hamline avenue north
building c
saint paul, MN 55112
MDR Report Key17552165
MDR Text Key321219630
Report Number2124215-2023-43651
Device Sequence Number1
Product Code FAE
UDI-Device Identifier08714729979357
UDI-Public08714729979357
Combination Product (y/n)N
Reporter Country CodeHU
PMA/PMN Number
K183619
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number720081-01
Device Catalogue Number720081-01
Device Lot Number0025479931
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/26/2023
Initial Date FDA Received08/15/2023
Supplement Dates Manufacturer ReceivedNot provided
10/11/2023
Supplement Dates FDA Received09/12/2023
11/01/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/27/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient SexMale
-
-